Clinical Trials in San Diego

Showing 9281-9300 of 14,679 trials

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients

NCT02164006

The purpose of this study is to evaluate the safety and effectiveness of TGR-1202 in combination with brentuximab vedotin in patients with hodgkin's lymphoma.

Hodgkin's Lymphoma

TG Therapeutics, Inc.16 participantsStarted Jun 2014

Duarte, California, United States • San Diego, California, United States • Sarasota, Florida, United States +1 more locations

COMPLETEDPhase 2< 1 mile

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

NCT01683409

This is a dose ranging study to evaluate the safety and efficacy of baricitinib in the treatment of participants with mild to moderate diabetic kidney disease.

Diabetic Kidney Disease

Eli Lilly and Company130 participantsStarted Aug 2012

Lancaster, California, United States • San Diego, California, United States • Torrance, California, United States +42 more locations

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Find Trials by Condition in San Diego

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

A Study in Second Line Metastatic Colorectal Cancer

Oxytocin Add-on for Stable Depressed Patients

Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

MRI to Detect Breast Tumors in Women

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

A Study in Advanced Solid Tumors

Study of Ramucirumab in Ovarian Cancer

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)